Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04002986 · ClinicalTrials.gov registry record · NA
Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 116
- Enrollment target
NCT04002986: Completed NA study, sponsored by Mayo Clinic.
NCT04002986 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 116 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04002986, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
Study Summary
Researchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer and how that information my assist providers in improving screening and preventative options.
Interventions
- GENETIC Genetic Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2019-08-20 |
| Est. Completion | 2021-05-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04002986
The ClinicalTrials.gov registry entry for NCT04002986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Genetic Testing is the first listed.
NCT04002986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04002986 about?
NCT04002986 is a clinical study titled "Comprehensive Genetic Assessment, Risk and Education in a Mammography Pilot". Researchers are trying to learn more about the prevalence of genetic mutations in women who are at intermediate/high risk of breast cancer and how that information my assist providers in improving screening and preventative options.
What is the current status of trial NCT04002986?
This trial is currently completed. It is a NA study. The enrollment target is 116 participants. The study started on 2019-08-20. Estimated completion is 2021-05-24.
What interventions are being tested in trial NCT04002986?
The interventions under investigation include: Genetic Testing (GENETIC).
Who is sponsoring clinical trial NCT04002986?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.